Form 4: Roivant Sciences Director Daniel Gold Reports Share Sale to Cover Tax Obligations

Director Daniel Allen Gold sold 2,599 common shares of Roivant Sciences Ltd. to cover tax obligations related to vested RSUs.

Summary

• On September 12, 2024, Daniel Allen Gold, a director of Roivant Sciences Ltd., sold 2,599 common shares of the company.
• The sale was executed at a price of $12.12 per share.
• This transaction was a 'net settlement' by Roivant Sciences to cover tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• Following the transaction, Gold directly owns 7,289,093 common shares.
• Gold also indirectly owns 2,656,245 common shares held by trusts and estate planning vehicles.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction appears to be routine, covering tax obligations related to vested equity.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates